November 17, 2023

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

 

Attn: Tim Buchmiller

 

Re: Sonoma Pharmaceuticals, Inc.
  Registration Statement on Form S-3
  Filed November 3, 2023
 

File No. 333-275311

 

Acceleration Request

 

Requested Date: November 20, 2023

Requested Time: 5:00 P.M. Eastern Standard Time

 

Dear Mr. Buchmiller:

 

Pursuant to Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Sonoma Pharmaceuticals, Inc. (the “Company”), hereby requests that the above-captioned Registration Statement on Form S-3, as amended, (the “Registration Statement”) be accelerated to November 20, 2023 at 5:00pm EST or as soon as practicable thereafter.

 

The cooperation of the staff in meeting the Company’s request is very much appreciated. Please contact me if you have any questions or if we can otherwise be of assistance to you.

 

Sincerely,

 

/s/ Amy Trombly

 

Amy Trombly, Esq.